Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-23-000524
Filing Date
2023-11-20
Accepted
2023-11-20 09:37:56
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-K rgbp093023form10k.htm   iXBRL 10-K 1826801
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 9503
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 9482
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 4229
10 EXHIBIT 32.2 ex32_2.htm EX-32.2 4101
  Complete submission text file 0001607062-23-000524.txt   5376450

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rgbp-20230930.xsd EX-101.SCH 54689
3 XBRL CALCULATION FILE rgbp-20230930_cal.xml EX-101.CAL 50214
4 XBRL DEFINITION FILE rgbp-20230930_def.xml EX-101.DEF 165437
5 XBRL LABEL FILE rgbp-20230930_lab.xml EX-101.LAB 296992
6 XBRL PRESENTATION FILE rgbp-20230930_pre.xml EX-101.PRE 239171
51 EXTRACTED XBRL INSTANCE DOCUMENT rgbp093023form10k_htm.xml XML 546131
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 231420984
SIC: 2834 Pharmaceutical Preparations